Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine
Clinical trial NCT00310713 · COMPLETED
Trial details
- NCT number
- NCT00310713
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2006-08-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.